Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1327)	12/26/1997 2:11:00 AM
From: BDR	Read Replies (1) \| Respond to of 7041

From slide #6- nearly 25% of "impotent" men had intercourse/orgasm on placebo. I will have to do some research to see if the same placebo effect has been seen with other agents, otherwise selection of patients is called into question. Second point from that slide- 40mg and 80mg doses improved the response rate to about 45%, about 20% more than placebo alone. So, better than placebo but not overwhelming. MUSE reported something like 67% in the trials but in actual practice it is perhaps 50%. If Vasomax experiences a similar decline in effectiveness in actual use the patient might as well take a sugar pill, is that the message? Longs, help me out. Make your case.